{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:01:41Z","timestamp":1770973301546,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cynata Therapeutics Limited"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jcyt.2015.10.013","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T18:59:05Z","timestamp":1451329145000},"page":"219-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice"],"prefix":"10.1016","volume":"18","author":[{"given":"Jill M.","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saritha S.","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise J.","family":"Schwahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2015.10.013_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/bmb\/lds027","article-title":"Peripheral arterial disease: a literature review","volume":"104","author":"Abdulhannan","year":"2012","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999\u20132000","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0020","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/CIRCRESAHA.113.300565","article-title":"Cell therapy of peripheral arterial disease: from experimental findings to clinical trials","volume":"112","author":"Raval","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0025","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","article-title":"Peripheral arterial disease: morbidity and mortality implications","volume":"114","author":"Golomb","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/scrt119","article-title":"Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia","volume":"3","author":"Liew","year":"2012","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0035","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1160\/TH09-10-0688","article-title":"Stem cell and progenitor cell therapy in peripheral artery disease","volume":"103","author":"Lawall","year":"2010","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.jcyt.2015.10.013_bib0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0045","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","article-title":"Use of mesenchymal stem cells for therapy of cardiac disease","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.jcyt.2015.10.013_bib0050","doi-asserted-by":"crossref","first-page":"e2213","DOI":"10.1371\/journal.pone.0002213","article-title":"Replicative senescence of mesenchymal stem cells: a continuous and organized process","volume":"3","author":"Wagner","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0055","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/jcb.24166","article-title":"Functional heterogeneity of mesenchymal stem cells: implications for cell therapy","volume":"113","author":"Phinney","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0060","doi-asserted-by":"crossref","first-page":"E5039","DOI":"10.1073\/pnas.1309408110","article-title":"A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation","volume":"110","author":"Lei","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0065","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1161\/ATVBAHA.111.230938","article-title":"Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease","volume":"31","author":"Rufaihah","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.jcyt.2015.10.013_bib0070","doi-asserted-by":"crossref","first-page":"e57876","DOI":"10.1371\/journal.pone.0057876","article-title":"Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells","volume":"8","author":"Lai","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jcyt.2015.10.013_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCULATIONAHA.111.048264","article-title":"Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb","volume":"125","author":"Dar","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jcyt.2015.10.013_bib0080","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.109.898312","article-title":"Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice","volume":"121","author":"Lian","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2015.10.013_bib0135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1634\/stemcells.2006-0420","article-title":"Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs","volume":"25","author":"Lian","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0085","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.cell.2007.04.028","article-title":"Neuroepithelial cells supply an initial transient wave of MSC differentiation","volume":"129","author":"Takashima","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1634\/stemcells.20-3-205","article-title":"Origin and differentiation of human and murine stroma","volume":"20","author":"Dennis","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0095","doi-asserted-by":"crossref","first-page":"e03696","DOI":"10.7554\/eLife.03696","article-title":"The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function","volume":"3","author":"Isern","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.stem.2010.11.011","article-title":"A mesoderm-derived precursor for mesenchymal stem and endothelial cells","volume":"7","author":"Vodyanik","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0105","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2014.01.013","article-title":"MSC-based product characterization for clinical trials: an FDA perspective","volume":"14","author":"Mendicino","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0115","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0120","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/01.CIR.0000159345.00591.8F","article-title":"Angiogenesis: where do we stand now?","volume":"11","author":"Simons","year":"2005","journal-title":"Circulation"},{"issue":"Suppl. A","key":"10.1016\/j.jcyt.2015.10.013_bib0125","doi-asserted-by":"crossref","first-page":"A48","DOI":"10.1016\/j.jvs.2007.02.030","article-title":"The chemokine system in arteriogenesis and hind limb ischemia","volume":"45","author":"Shireman","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0140","series-title":"Skeletal muscle circulation","author":"Korthuis","year":"2011"},{"key":"10.1016\/j.jcyt.2015.10.013_bib0145","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/nprot.2009.185","article-title":"Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia","volume":"4","author":"Limbourg","year":"2009","journal-title":"Nat Protoc"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532491501107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532491501107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:22:35Z","timestamp":1761430955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532491501107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S146532491501107X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.10.013","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}